Image not available

Figure. Percentage of providers who state that the US Preventive Services Task Force draft recommendations will change their prostate-specific antigen (PSA) screening practice according to how strongly they agree or disagree with the draft recommendations. The sample included providers who had previously heard of the draft recommendations (N = 114).

 Screening for prostate cancer: draft recommendation statement AHRQ publication No. 12-05160-EF-2. US Preventive Services Task Force Web site. Accessed December 7, 2011
Wolf AM, Wender RC, Etzioni RB,  et al; American Cancer Society Prostate Cancer Advisory Committee.  American Cancer Society guideline for the early detection of prostate cancer: update 2010.  CA Cancer J Clin. 2010;60(2):70-98PubMedArticle
Greene KL, Albertsen PC, Babaian RJ,  et al.  Prostate specific antigen best practice statement: 2009 update.  J Urol. 2009;182(5):2232-2241PubMedArticle
Linder SK, Hawley ST, Cooper CP, Scholl LE, Jibaja-Weiss M, Volk RJ. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.  BMC Fam Pract. 2009;10:19PubMedArticleArticle
Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.  J Clin Oncol. 2011;29(13):1736-1743PubMedArticle
Research Letters
Apr 23, 2012

Primary Care Providers' Response to the US Preventive Services Task Force Draft Recommendations on Screening for Prostate Cancer

Author Affiliations

Author Affiliations: Division of General Internal Medicine (Drs Pollack and Bhavsar), Department of Pediatrics (Dr Bhavsar), and The James Buchanan Brady Urological Institute (Dr Carter), Johns Hopkins University School of Medicine, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health (Drs Pollack and Bhavsar), and Johns Hopkins Community Physicians (Drs Noronha and Green), Baltimore, Maryland.

Arch Intern Med. 2012;172(8):668-670. doi:10.1001/archinternmed.2012.135